Capricor Therapeutics will host an investor webcast on Tuesday, September 24, 2024 at 8:30 a.m. ET to provide an update on its Duchenne muscular dystrophy program. The update will consist of the latest regulatory updates following the Company’s recent meetings with the U.S. Food and Drug Administration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Biotech Alert: Searches spiking for these stocks today
- Capricor Therapeutics price target raised to $15 from $14 at Oppenheimer
- Capricor expands partnership with Nippon in Europe, says Maxim
- Capricor Therapeutics Secures Lucrative European Partnership
- Capricor Therapeutics enters deramiocel term sheet with Nippon Shinyaku